Stem Cell Therapeutic and Research Reauthorization (HR 5160)

119 HR 5160 IH: Stem Cell Therapeutic and Research Reauthorization Act of 2025 U.S. House of Representatives 2025-09-04 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 119th CONGRESS 1st Session H. R. 5160 IN THE HOUSE OF REPRESENTATIVES September 4, 2025 Mr. Smith of New Jersey (for himself, Ms. Matsui , Mr. Bilirakis , Ms. Pingree , Ms. Tenney , and Mr. Mfume ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes. 1. Short title This Act may be cited as the Stem Cell Therapeutic and Research Reauthorization Act of 2025 . 2. Reauthorization of the C.W. Bill Young Cell Transplantation Program Section 379B of the Public Health Service Act ( 42 U.S.C. 274m ) is amended— (1) by striking appropriated $31,009,000 and inserting the following: appropriated— (1) $31,009,000 ; (2) in paragraph (1), as so inserted, by striking the period at the end and inserting ; and ; and (3) by adding at the end the following: (2) $33,009,000 for each of fiscal years 2027 through 2031. . 3. Cord blood inventory Section 2(g) of the Stem Cell Therapeutic and Research Act of 2005 ( 42 U.S.C. 274k note) is amended by striking 2026 and inserting 2031 .